SAT-643 Predictors of Technology Success in Cystic Fibrosis Related Diabetes

por Jain, Ashna, Kaminski, Beth Anne, Kutney, Katherine
Publicado 2020

COVID-19: Pathophysiology and implications for cystic fibrosis, diabetes and cystic fibrosis-related diabetes

por Mason, Kelly, Hasan, Sana, Darukhanavala, Amy, Kutney, Katherine
Publicado 2021

Cystic fibrosis related liver disease and endocrine considerations

por Sherwood, Jordan S., Ullal, Jagdeesh, Kutney, Katherine, Hughan, Kara S.
Publicado 2021

Obesity in cystic fibrosis

por Kutney, Katherine A., Sandouk, Zahrae, Desimone, Marisa, Moheet, Amir
Publicado 2021

Treatment of cystic fibrosis related bone disease

por Ullal, Jagdeesh, Kutney, Katherine, Williams, Kristen M., Weber, David R.
Publicado 2021

Reproducibility of in-home CFRD screening using continuous glucose monitoring and mixed meal tolerance test

por Kutney, Katherine, Kaminski, Beth A., Casey, Terri, O'Riordan, MaryAnn, Gubitosi-Klug, Rose
Publicado 2023

Lumacaftor/ivacaftor therapy is associated with reduced hepatic steatosis in cystic fibrosis patients

por Kutney, Katherine, Donnola, Shannon B, Flask, Chris A, Gubitosi-Klug, Rose, O’Riordan, MaryAnn, McBennett, Kimberly, Sferra, Thomas J, Kaminski, Beth
Publicado 2019